Choosing an EMR for Addiction Treatment

How do you choose an EMR for addiction treatment?

Addiction-treatment programs may span several levels of care and involve group services, addiction medications, payer utilization review, and records subject to special confidentiality rules. A structured selection process should map those workflows, assign clinical and compliance owners, and test each candidate using a shared test script covering those workflows before contract approval.

This guide walks through that process in five steps, plus a criteria table you can use to score a shortlist.

Step 1: Map your levels of care and daily workflows

Before you look at any vendor, document how care actually moves through your program. This becomes the backbone of every requirement you write later.

• Levels of care you offer — withdrawal management (sometimes called detox), residential, PHP, IOP, and outpatient — including how clients transition between them
• Group vs. individual documentation — how many groups run per day, and how notes get attached to each participant
• Admissions-to-discharge path — inquiry, verification of benefits, intake, treatment planning, discharge, and alumni follow-up
• Medication workflows — medication history, orders, pharmacy routing, and the roles involved; flag controlled-substance workflows for separate EPCS and state PDMP review
• Payer mix — which payers require authorizations, concurrent review, or specific documentation to support medical necessity

Write this down as a workflow map, not a wish list. It’s the reference document you’ll hold every vendor demo against.

Step 2: Build addiction-specific clinical, prescribing, payer, and privacy requirements

With the workflow map in hand, translate it into concrete platform requirements. Four areas commonly need program-specific review:

• Assessment and placement. If the organization, payer, or jurisdiction uses the ASAM Criteria, verify the licensed edition, assessment workflow, decision support, overrides, and documentation rather than assuming the vendor’s “ASAM-aligned” label defines the scope.
• Medication and prescribing workflows. Treat medication history, order entry, prescription transmission or pharmacy routing, role permissions, exceptions, and audit evidence as baseline workflow and product checks—not as proof that a prescribing workflow meets every applicable requirement. For every prescribing workflow, have prescribing or pharmacy-compliance owners identify the requirements that apply to the medication, professional role, location, and jurisdiction, then turn those requirements into test cases. If practitioners will electronically prescribe controlled substances, separately evaluate the system and implementation against the federal EPCS requirements in 21 CFR Part 1311, Subpart C. The same owners should determine whether and how state PDMP or other controlled-substance requirements apply rather than treating them as universal.
• Utilization review and authorizations. Map current payer, plan, service, documentation, authorization, coding, and contract requirements without treating authorization as a payment guarantee or reimbursement pressure as a clinical decision.
• 42 CFR Part 2 workflows. If the organization creates or maintains records subject to 42 CFR Part 2, have legal and privacy owners determine which current provisions apply. Translate that determination into testable requirements for the configured system, such as its handling of applicable consents, disclosures, user access, notices, and audit evidence; do not treat a vendor compliance label as the legal analysis.

Separate gates from preferences before assigning scores. Requirements identified by the responsible owners as mandatory for legal, safety, privacy, clinical-continuity, data-access, payer-contract, or other contractual reasons should be pass/fail gates; a candidate should not overcome a failed gate with a high total score elsewhere. Weight the remaining preferences using workflow frequency, manual-workaround burden, operational impact, and implementation effort.

Step 3: Map system boundaries and external dependencies

Decide which functions must live in the EMR and which may be handled by a pharmacy, laboratory, PDMP connection, clearinghouse, billing service, CRM, or another system. For every boundary, record the data exchanged, system of record, reconciliation owner, downtime process, privacy constraints, fees, and export rights. This turns an “all-in-one” claim into a testable architecture question rather than a buying premise.

Step 4: Run scenario-based demos, not feature tours

A repeatable script makes demonstrations easier to compare. Use representative, non-production data and ask each vendor to cover the same roles and exceptions:

• Admit a client at one level of care, document a group session, and step them up to another level
• Review a consent, access, and disclosure scenario defined by the organization’s legal and privacy owners
• Run an ordinary prescribing scenario with the relevant roles and the requirements identified for that workflow. If EPCS applies, separately test access controls, signing authentication, changes before signing, exceptions, and audit evidence. If a PDMP workflow applies, test the jurisdiction-specific query, documentation, exception, and downtime steps identified by the prescribing or pharmacy-compliance owner
• Walk a claim from verification of benefits through authorization to a submitted claim
• Pull a report your leadership team actually asks for weekly

Record what is native, configured, integrated, manual, out of scope, or dependent on another vendor. That evidence is more useful than a feature checkbox.

Step 5: Evaluate migration, security, and contract terms before you sign

Use the proposal, implementation plan, security materials, and draft agreement to verify what the demonstration did not establish. Record each answer with its owner and the document or contract section that controls it. Ask directly:

• Scope and price: Which modules, services, interfaces, environments, training, and support are included? List implementation, interface, migration, usage, third-party, and recurring fees, along with pricing assumptions and permitted price changes.
• Responsibilities and acceptance: What must the vendor, customer, and any interface partner deliver? Put milestones, dependencies, data preparation, testing, acceptance criteria, and consequences of failed acceptance in writing.
• Migration and cutover: Which discrete fields, notes, attachments, medications, consents, audit history, and inactive records will migrate, in what form? Define mapping, validation, rejected-record handling, parallel access, cutover, rollback, and continuity responsibilities.
• Security commitments: Which current security documentation will the vendor provide, and which promised controls, incident-response and notification duties, subcontractor terms, review rights, and customer responsibilities will appear in the agreement?
• Data rights and export: Who controls the customer data, and what can be exported during service and at exit? Specify format, completeness, timing, frequency, fees, attachments and metadata, post-termination access, retention, and deletion.
• Support and service levels: Define support hours, severity levels, response and restoration targets, escalation contacts, maintenance windows, status communications, and any credits, termination rights, or other remedies.
• Product changes: How are customers notified of material workflow, interface, security, or regulatory-support changes, and what testing, configuration, training, or additional fees can those changes require?
• Renewal, termination, and transition: Review renewal notice, price changes, suspension and termination rights, transition assistance, interface wind-down, final exports, and the time and cost allowed to move to another system.

Before approval, confirm that every pass/fail gate is supported by the signed documents rather than a sales statement. The relevant operational, clinical, privacy, security, finance, and prescribing owners should validate their requirements; counsel should interpret legal obligations and contract language for the organization.

Evaluation criteria at a glance

Use this table to compare a shortlist side by side. Mark each applicable gate pass, fail, or unresolved before calculating weighted scores for the remaining preferences.

Where Sunwave fits

Sunwave’s current behavioral health EMR page advertises a single patient file along with scheduling, clinical documentation, a client portal, medication-management functions, billing workflows, telehealth, and AI-generated documentation. These are vendor-described capabilities, not independent evidence of performance, security, compliance, or clinical results. Verify their scope, dependencies, configuration, migration work, service commitments, and contract terms through the same scripted evaluation used for every candidate.

This article is educational and describes software capabilities and general industry practices; it is not legal, clinical, financial, or billing advice. Requirements vary by organization, payer, program, and jurisdiction. Sunwave Health is a behavioral health software platform. Schedule a demo.